Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Avita Medical Inc (RCEL)

Avita Medical Inc (RCEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 463,812
  • Shares Outstanding, K 24,896
  • Annual Sales, $ 29,230 K
  • Annual Income, $ -26,580 K
  • 60-Month Beta 0.99
  • Price/Sales 16.12
  • Price/Cash Flow N/A
  • Price/Book 4.49
Trade RCEL with:

Options Overview

Details
  • Implied Volatility 55.34%
  • Historical Volatility 51.64%
  • IV Percentile 4%
  • IV Rank 20.53%
  • IV High 130.32% on 08/17/21
  • IV Low 35.97% on 04/20/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 29
  • Volume Avg (30-Day) 19
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 113
  • Open Int (30-Day) 124

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.40
  • Number of Estimates 2
  • High Estimate -0.36
  • Low Estimate -0.44
  • Prior Year -0.48
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.77 +11.09%
on 08/20/21
21.21 -12.16%
on 09/03/21
+1.64 (+9.65%)
since 08/17/21
3-Month
16.52 +12.77%
on 08/17/21
22.49 -17.16%
on 06/25/21
-1.96 (-9.52%)
since 06/17/21
52-Week
16.52 +12.77%
on 08/17/21
29.34 -36.50%
on 09/18/20
-9.97 (-34.86%)
since 09/17/20

Most Recent Stories

More News
Acadia Healthcare (ACHC) Starts Building New Behavioral Facility

Acadia Healthcare (ACHC) opens a new behavioral facility to tap the growing market of mental illness.

CYH : 11.23 (+1.91%)
HCA : 258.74 (-1.11%)
ACHC : 61.22 (+3.13%)
RCEL : 18.63 (-1.58%)
AVITA Medical to Present at the 2021 Cantor Virtual Global Healthcare Conference

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple...

RCEL : 18.63 (-1.58%)
AVITA Medical to Participate at the Lake Street 2021 BIG5 Conference

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple...

AVMXY : 7.8900 (+9.13%)
RCEL : 18.63 (-1.58%)
AVITA Medical Reports Fourth Quarter and Fiscal Year 2021 Financial Results

AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration...

AVMXY : 7.8900 (+9.13%)
RCEL : 18.63 (-1.58%)
FDA Approves IDE Amendment to a Single-Arm Design for AVITA Medical's Pivotal Study of the RECELL(R) System for Vitiligo Treatment

-- New single-arm design to evaluate 23 subjects at 15 clinical sites, versus previously approved 3-arm study of 84 subjects

AVMXY : 7.8900 (+9.13%)
RCEL : 18.63 (-1.58%)
AVITA Medical to Announce Fiscal Fourth Quarter 2021 Financial Results

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple...

AVMXY : 7.8900 (+9.13%)
RCEL : 18.63 (-1.58%)
AVITA Medical Announces Inclusion in the Russell 3000 Index

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple...

AVMXY : 7.8900 (+9.13%)
RCEL : 18.63 (-1.58%)
AVITA Medical Announces Preliminary Fourth Quarter 2021 Financial Results

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple...

AVMXY : 7.8900 (+9.13%)
RCEL : 18.63 (-1.58%)
U.S. Food and Drug Administration Approves Expanded Use of the RECELL(R) System for the Treatment of Extensive Burns and Pediatric Patients

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple...

AVMXY : 7.8900 (+9.13%)
RCEL : 18.63 (-1.58%)
AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors

AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) ("AVITA Medical"), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration...

AVMXY : 7.8900 (+9.13%)
RCEL : 18.63 (-1.58%)
SCL : 111.53 (-2.18%)
ANGO : 25.31 (-6.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

AVITA Medical Inc. is a regenerative medicine company. It engages in developing and commercializing a technology platform which enables point-of-care autologous skin restoration for multiple unmet needs. AVITA Medical Inc., formerly known as AVITA Therapeutics Inc., is based in VALENCIA, Calif.

See More

Key Turning Points

3rd Resistance Point 19.54
2nd Resistance Point 19.24
1st Resistance Point 18.94
Last Price 18.63
1st Support Level 18.34
2nd Support Level 18.04
3rd Support Level 17.74

See More

52-Week High 29.34
Fibonacci 61.8% 24.44
Fibonacci 50% 22.93
Fibonacci 38.2% 21.42
Last Price 18.63
52-Week Low 16.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar